Clinical Trial Update: Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update outlines a Phase 1/Phase 2 study evaluating the combination of liposomal mitoxantrone hydrochloride and Enlonstobart in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Enlonstobart
• Mitoxantrone hydrochloride liposome (Mitoxantrone hydrochloride liposome)

Snippet

Sponsor: Sun Yat-Sen University Cancer Center | Conditions: Relapsed or Refractory Peripheral T Cell Lymphoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING